At Rush University Medical Center, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.

Excellence is just the beginning.


French German Italian Portuguese Russian

Study of the Optimal Evaluation of Cardiac Symptoms and Revascularization

Clinical Trial Title: 
PRECISE: Prospective randomized trial of the optimal evaluation of cardiac symptoms and revascularization.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Dinesh K. Kalra, MD
Clinical Trial Protocol Description: 

The purpose of this study is to assess clinical outcomes, as well as physician decision making regarding noninvasive testing and invasive angiography in patients with stable symptoms suggestive of coronary artery disease (CAD). Patients will be assigned an evaluation strategy based on a pre-test risk assessment and randomized to either precision care or usual care. The precision care group will incorporate either cCTA with selective FFR-CT and guideline recommended care or symptom and risk factor management with no immediately planned testing. The usual care arm will be evaluated at their physician’s discretion.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are 18 years old or older.
  • Have stable symptoms suggesting CAD
  • Have stable kidney function (creatinine clearance >45 mL/min).

You will be excluded from the study if any of the following criteria apply to you:

  • Have acute chest pain.
  • Have received any cardiovascular testing for CAD (stress test, angiogram, cCTA) within 1 year.

This is a partial list of inclusion and exclusion criteria. To inquire about your eligibility, please call the contact number provided.

Clinical Trial Area: 
Heart and Vascular Conditions
Contact Phone: 
(312) 942-8144
Contact Name: 
Jennifer Fernandez